Company Name

Industry

Location

Revenue

Employees

Visterra

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Orna Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Pieris Pharmaceuticals

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Ikena Oncology

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Affini-T Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Good Start Genetics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Vigil Neuroscience

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

X4 Pharmaceuticals

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

TScan Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

QurAlis

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Curiox Biosystems

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Neon Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Mersana Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

HotSpot Therapeutics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Pyxis Oncology

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Ensoma

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Sengenics

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Genuity Science

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Xyleco

Biotechnology

United States, Massachusetts

$10M to $25M

51-200

Histogenics Corporation

Biotechnology

United States, Massachusetts

$10M to $25M

51-200